Chagas Disease: A Silent Threat for Dogs and Humans

被引:7
作者
Duraes-Oliveira, Joao [1 ]
Palma-Marques, Joana [1 ]
Moreno, Claudia [1 ]
Rodrigues, Armanda [1 ]
Monteiro, Marta [1 ,2 ,3 ]
Alexandre-Pires, Graca [2 ,3 ]
da Fonseca, Isabel Pereira [2 ,3 ]
Santos-Gomes, Gabriela [1 ]
机构
[1] Univ NOVA Lisboa, Associate Lab Translat & Innovat Global Hlth, Global Hlth & Trop Med, GHTM,LA REAL,IHMT,Inst Higiene & Med Trop,UNL, Rua Junqueira 100, P-1349008 Lisbon, Portugal
[2] Univ Lisbon, Fac Vet Med, Ctr Interdisciplinary Res Anim Hlth, CIISA,FMV, P-1649004 Lisbon, Portugal
[3] Associate Lab Anim & Vet Sci AL4AnimalS, P-1300477 Lisbon, Portugal
关键词
Trypanosoma cruzi; Chagas disease; zoonotic infection; reservoir; dogs; medical advances; clinical signs; vaccines; TRYPANOSOMA-CRUZI INFECTION; AMERICAN TRYPANOSOMIASIS; ORAL-TRANSMISSION; IN-VITRO; BENZNIDAZOLE TREATMENT; GENETIC-VARIABILITY; VACCINE CANDIDATES; DNA VACCINES; RURAL AREA; CARDIOMYOPATHY;
D O I
10.3390/ijms25073840
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Chagas disease (CD) is a vector-borne Neglected Zoonotic Disease (NZD) caused by a flagellate protozoan, Trypanosoma cruzi, that affects various mammalian species across America, including humans and domestic animals. However, due to an increase in population movements and new routes of transmission, T. cruzi infection is presently considered a worldwide health concern, no longer restricted to endemic countries. Dogs play a major role in the domestic cycle by acting very efficiently as reservoirs and allowing the perpetuation of parasite transmission in endemic areas. Despite the significant progress made in recent years, still there is no vaccine against human and animal disease, there are few drugs available for the treatment of human CD, and there is no standard protocol for the treatment of canine CD. In this review, we highlight human and canine Chagas Disease in its different dimensions and interconnections. Dogs, which are considered to be the most important peridomestic reservoir and sentinel for the transmission of T. cruzi infection in a community, develop CD that is clinically similar to human CD. Therefore, an integrative approach, based on the One Health concept, bringing together the advances in genomics, immunology, and epidemiology can lead to the effective development of vaccines, new treatments, and innovative control strategies to tackle CD.
引用
收藏
页数:25
相关论文
共 197 条
  • [21] A therapeutic vaccine prototype induces protective immunity and reduces cardiac fibrosis in a mouse model of chronic Trypanosoma cruzi infection
    Barry, Meagan A.
    Versteeg, Leroy
    Wang, Qian
    Pollet, Jeroen
    Zhan, Bin
    Gusovsky, Fabian
    Bottazzi, Maria Elena
    Hotez, Peter J.
    Jones, Kathryn M.
    [J]. PLOS NEGLECTED TROPICAL DISEASES, 2019, 13 (05):
  • [22] A therapeutic nanoparticle vaccine against Trypanosoma cruzi in a BALB/c mouse model of Chagas disease
    Barry, Meagan A.
    Wang, Qian
    Jones, Kathryn M.
    Heffernan, Michael J.
    Buhaya, Munir H.
    Beaumier, Coreen M.
    Keegan, Brian P.
    Zhan, Bin
    Dumonteil, Eric
    Bottazzi, Maria Elena
    Hotez, Peter J.
    [J]. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2016, 12 (04) : 976 - 987
  • [23] Acute Trypanosoma cruzi infection:: IL-12, IL-18, TNF, sTNFR and NO in T. rangeli-vaccinated mice
    Basso, B
    Cervetta, L
    Moretti, E
    Carlier, Y
    Truyens, C
    [J]. VACCINE, 2004, 22 (15-16) : 1868 - 1872
  • [24] Vaccination with epimastigotes of different strains of Trypanosoma rangeli protects mice against Trypanosoma cruzi infection
    Basso, Beatriz
    Moretti, Edgardo
    Fretes, Ricardo
    [J]. MEMORIAS DO INSTITUTO OSWALDO CRUZ, 2008, 103 (04): : 370 - 374
  • [25] Vaccination with Trypanosoma rangeli reduces the infectiousness of dogs experimentally infected with Trypanosoma cruzi
    Basso, Beatriz
    Castro, Irma
    Introini, Virginia
    Gil, Patricia
    Truyens, Carine
    Moretti, Edgardo
    [J]. VACCINE, 2007, 25 (19) : 3855 - 3858
  • [26] Chagas disease in a domestic transmission cycle in southern Texas, USA
    Beard, CB
    Pye, G
    Steurer, FJ
    Rodriguez, R
    Campman, R
    Peterson, AT
    Ramsey, J
    Wirtz, RA
    Robinson, LE
    [J]. EMERGING INFECTIOUS DISEASES, 2003, 9 (01) : 103 - 105
  • [27] BERGER SL, 1991, J AM VET MED ASSOC, V198, P132
  • [28] Evaluation and treatment of Chagas disease in the United States - A systematic review
    Bern, Caryn
    Montgomery, Susan P.
    Herwaldt, Barbara L.
    Rassi, Anis, Jr.
    Marin-Neto, Jose Antonio
    Dantas, Roberto O.
    Maguire, James H.
    Acquatella, Harry
    Morillo, Carlos
    Kirchhoff, Louis V.
    Gilman, Robert H.
    Reyes, Pedro A.
    Salvatella, Roberto
    Moore, Anne C.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 298 (18): : 2171 - 2181
  • [29] Trypanosoma cruziloop-mediated isothermal amplification (Trypanosoma cruziLoopamp) kit for detection of congenital, acute and Chagas disease reactivation
    Besuschio, Susana A.
    Picado, Albert
    Munoz-Calderon, Arturo
    Wehrendt, Diana P.
    Fernandez, Marisa
    Benatar, Alejandro
    Diaz-Bello, Zoraida
    Irurtia, Cecilia
    Cruz, Israel
    Ndung'u, Joseph M.
    Cafferata, Maria L.
    Montenegro, Graciela
    Sosa Estani, Sergio
    Lucero, Raul H.
    Alarcon de Noya, Belkisyole
    Longhi, Silvia A.
    Schijman, Alejandro G.
    [J]. PLOS NEGLECTED TROPICAL DISEASES, 2020, 14 (08): : 1 - 17
  • [30] Utility of the Trypanosoma cruzi sequence database for identification of potential vaccine candidates by in silico and in vitro screening
    Bhatia, V
    Sinha, M
    Luxon, B
    Garg, N
    [J]. INFECTION AND IMMUNITY, 2004, 72 (11) : 6245 - 6254